Cite
HARVARD Citation
Anderson, M. et al. (2022). A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1–Related Plexiform Neurofibromas. Annals of pharmacotherapy. 56 (6), pp. 716-726. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Anderson, M. et al. (2022). A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1–Related Plexiform Neurofibromas. Annals of pharmacotherapy. 56 (6), pp. 716-726. [Online].